The report "Influenza Diagnostics Market is on a remarkable trajectory, with a projected value of USD 1.1 billion by 2026, exhibiting a robust CAGR of 7.7% during the forecast period. This growth can be attributed to several key factors, including the increasing prevalence of influenza, burgeoning research in diagnostic technologies for influenza, and the surging demand for swift disease diagnosis. However, the market faces certain obstacles, such as variations in test sensitivity and specificity, as well as rising healthcare costs. Despite these challenges, the market's potential remains promising, fueled by technological advancements and rising awareness of the significance of early influenza detection.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222985562

Browse in-depth TOC on "Influenza Diagnostics Market”

176 – Tables

39 – Figures

198 – Pages

Key Market

Prominent companies in the influenza diagnostics market include Danaher Corporation (US), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories, Inc. (Us), Hologic, Inc. (US), bioMérieux SA (France), Quidel Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics, Inc. (US), Luminex Corporation (US), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), altona Diagnostics GmbH (Germany), SEKISUI Diagnostics (US), SA Scientific Ltd. (US), Coris BioConcept SPRL (Belgium), ELITech Group (France), Mast Group Ltd. (UK), Genome Diagnostics, Pvt. Ltd. (India), Germaine Laboratories, Inc. (US), Response Biomedical Corp. (Canada). Tauns Laboratories, Inc. (Japan) and 3B BlackBio Biotech India Ltd. (India)

Factors Driving Growth:

  1. Escalating Prevalence of Influenza: Influenza continues to pose a significant public health concern globally, with a rising number of cases reported each year. As a result, the demand for reliable and accurate influenza diagnostics has surged, driving the growth of the market.
  2. Advancements in Influenza Research: The relentless efforts in influenza research have led to the development of cutting-edge diagnostic technologies. This continuous exploration has significantly enhanced the accuracy and efficiency of influenza diagnosis, attracting greater adoption in the healthcare sector.
  3. Surging Demand for Rapid Disease Diagnosis: In the fast-paced world, timely diagnosis is critical for effective disease management. The rising demand for swift and accurate diagnosis of influenza has spurred the adoption of advanced influenza diagnostic tools, boosting market growth.

Challenges Ahead:

  1. Variability in Test Sensitivity and Specificity: Ensuring consistent test sensitivity and specificity remains a challenge in the influenza diagnostics market. Manufacturers are striving to develop more reliable testing methods to address this concern and enhance overall diagnostic accuracy.
  2. Rising Healthcare Costs: The economic burden associated with healthcare has been rising, affecting the affordability of diagnostic tests for influenza. However, ongoing efforts to streamline healthcare costs and government initiatives may aid in mitigating this challenge over time.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222985562

The Influenza Diagnostics Market encompasses the diagnostic tests used for the detection and diagnosis of influenza, commonly known as the flu. Influenza is a contagious respiratory illness caused by the influenza virus, and accurate and timely diagnosis is essential for effective disease management, patient care, and public health measures.

These companies offer a range of diagnostic tests and systems for influenza detection.

It's important to note that the influenza diagnostics market is dynamic, with ongoing advancements in technology. For the most up-to-date information, it is advisable to refer to market research reports, industry publications, and consult healthcare professionals and experts.

Top of Form

North America is the largest regional market for influenza diagnostics market

The global influenza diagnostics market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the influenza diagnostics market. The large share of this region can be attributed to growth in influenza research for diagnostic technologies and rising demand for rapid disease diagnosis.

Request 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1256

Recent Developments:

  • In May 2021 Becton, Dickinson and Company (US) received FDA approval for the BD Veritor Plus System, which is used to detect SARS-CoV-2, influenza A, and influenza B.
  • In March 2021, Abbott Laboratories, Inc. (US) received emergency use authorization (EUA) from the FDA for a laboratory PCR assay that detects and differentiates SARS-COV-2, flu A, flu B, and RSV in one test.
  • In February 2021, Becton, Dickinson and Company (US) received approval from the FDA for the emergency use authorization (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and influenza A+B.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/influenza-diagnostic-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/influenza-diagnostic.asp